MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

waiting for the outcome of a trial. nothing else m

  1. 22,691 Posts.
    Whatever has been said about MBP, it is the Phase II trial what really matters.

    Because slimming/losing fat is one of the world's biggest businesses, I am in no doubt as to the importance of MBP, should this trial be successful.

    About 40% of Patients would have completed the course by now.

    As to their PR, one of the items overlooked is to have an official listing at the Nasdaq and perhaps much later at AIM.

    Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.